Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Tuberculosis

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Seroprevalence of SARS-CoV-2 in pediatric hematology-oncology patients.

Pediatric blood & cancer·2024

Same author

Sequential Laser-Burned Lignin and Hydrogen Evolution-Assisted Copper Electrodeposition to Manufacture Wearable Electronics.

ACS applied materials & interfaces·2023

Same author

Risk Factors for Urinary Retention After Colpocleisis.

Female pelvic medicine & reconstructive surgery·2021

Same author

Exposure to Aerosolized Algal Toxins in South Florida Increases Short- and Long-Term Health Risk in <i>Drosophila</i> Model of Aging.

Toxins·2020

Same author

Driving change: A partnership study protocol using shared emergency department data to reduce alcohol-related harm.

Emergency medicine Australasia : EMA·2019

Same author

Why do 'fast track' patients stay more than four hours in the emergency department? An investigation of factors that predict length of stay.

Emergency medicine Australasia : EMA·2018

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Progress in tuberculosis eradication in Ireland.

Michael Sheridan¹

¹Department of Agriculture, Fisheries and Food, Kildare Street, Dublin 2, Ireland. Michael.Sheridan@agriculture.gov.ie

Veterinary Microbiology

|April 13, 2011

Summary

This summary is machine-generated.

Ireland's long-standing Bovine Tuberculosis (TB) eradication program faced challenges, necessitating a shift towards an interim control strategy. Ongoing research and development aim to overcome constraints and achieve eventual disease eradication.

Related Experiment Videos

Last Updated: Jun 2, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Area of Science:

Veterinary Public Health
Infectious Disease Control
Animal Health Management

Background:

Ireland implemented a conventional test-and-slaughter Bovine Tuberculosis eradication program from 1954 to 1988.
This program, while meeting trade requirements, did not achieve complete eradication of Bovine Tuberculosis (TB).
A major initiative, ERAD, was launched in 1988 to halve disease levels and develop a strategy for final eradication, with lessons learned informing subsequent programs.

Purpose of the Study:

To outline recent developments in Ireland's Bovine Tuberculosis control program.
To detail the ongoing research and development efforts to overcome constraints to eradication.
To present expectations for future progress in achieving Bovine Tuberculosis eradication.

Main Methods:

Review of historical Bovine Tuberculosis eradication program data and outcomes.
Analysis of the strategic shift towards an interim control program since 1992.
Description of investments in research and development to address wildlife reservoirs and other constraints.

Main Results:

The conventional program failed to eradicate Bovine Tuberculosis.
Significant resources are now invested in research and development to address disease constraints.
Policy decisions are informed by scientific evidence and stakeholder input.

Conclusions:

Bovine Tuberculosis eradication requires addressing wildlife reservoirs and other complex constraints.
Ireland's current program is an interim control strategy focused on R&D for eventual eradication.
Continued scientific advancement and stakeholder collaboration are crucial for future progress.